Evidence map›Paper›PMID 26807536›Full record

Trial reportMedical care2016

Comparative Responsiveness of the PROMIS Pain Interference Short Forms, Brief Pain Inventory, PEG, and SF-36 Bodily Pain Subscale.

Jacob Kean, Patrick O Monahan, Kurt Kroenke, Jingwei Wu, Zhangsheng Yu, Tim E Stump, Erin E Krebs

4 registry-linked trialsOpen access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Medical care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04884763 phase2completednot on this mapstarted 2021, after this paper: background citation

A Randomized, Double Blind, Placebo-Controlled Single Center Phase 2 Pilot Study to Assess the Safety and Efficacy of Off-label Subcutaneous Administration of Erenumab-aooe in Patients With Temporomandibular Disorder

TypeinterventionalSponsorIndiana UniversityRan2021 to 2024Enrolled30ConditionsTemporomandibular DisorderArmsErenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments, Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments
NCT05090683 nacompletednot on this mapstarted 2021, after this paper: background citation

Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.

TypeinterventionalSponsorUniversity of the Fraser ValleyRan2021 to 2022Enrolled198ConditionsChronic Pain, Migraine, Chronic Pain SyndromeArmsMind-body mobile application
NCT05846087 nacompletednot on this mapstarted 2023, after this paper: background citation

Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia: a Randomized Controlled Trial With Internal Pilot Study

TypeinterventionalSponsorWoolcock Institute of Medical ResearchRan2023 to 2025Enrolled106ConditionsChronic Low-back Pain, InsomniaArmssleep retraining therapy, sleep health education modules
NCT07143396 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of a Mind-Body Application in Combination With a Graded Movement Program for the Treatment of Chronic Pain

TypeinterventionalSponsorUniversity of the Fraser ValleyRan2025 to 2025Enrolled100ConditionsChronic Pain, Migraine, Chronic Pain SyndromeArmsMind-body mobile application and guided movement
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Integrative Treatment Strategies for Chronic Back Pain: A Literature Review with Clinical Recommendations.International journal of environmental research and public health · 2025
    Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jacob Kean*VA Salt Lake City Health Care System †Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT ‡Department of Biostatistics, Indiana University School of Medicine §Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service CIN 13-416, Richard L. Roudebush VA Medical Center, Center for Health Information and Communication ∥Regenstrief Institute ¶Department of Medicine, Indiana University School of Medicine, Indianapolis, IN #Center for Chronic Disease Outcomes Research, Minneapolis VA Health Care System **University of Minnesota Medical School, Minneapolis, MN.
Patrick O Monahan
Kurt Kroenke
Jingwei Wu
Zhangsheng Yu
Tim E Stump
Erin E Krebs
Department of Veterans Affairs · AUHealth Services Research & Development · US

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Responsiveness and Clinical Validity of PROMIS Pain and Depression MeasuresR01AR064081 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI MONAHAN, PATRICK O. · 2012 to 2015
$938k
Measurement-Based Telehealth Care of Mild Traumatic Brain InjuryIK2RX000879 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI KEAN, JACOB T. · 2012 to 2017
–
HSRD VA IIR 07-119NCATS NIH HHS UL1 TR001108NIAMS NIH HHS R01 AR064081RRD VA IK2 RX000879
6 · The paper itself

Abstract

purposeTo compare the sensitivity to change and the responsiveness to intervention of the PROMIS Pain Interference short forms, Brief Pain Inventory (BPI), 3-item PEG scale, and SF-36 Bodily Pain subscale in a sample of patients with persistent musculoskeletal pain of moderate severity.

methodsStandardized response means, standardized effect sizes, and receiver operating curve analyses were used to assess change between baseline and 3-month assessments in 250 participants who participated in a randomized clinical effectiveness trial of collaborative telecare management for moderate to severe and persistent musculoskeletal pain.

resultsThe BPI, PEG, and SF-36 Bodily Pain measures were more sensitive to patient-reported global change than the PROMIS Pain Interference short forms, especially for the clinically improved group, for which the change detected by the PROMIS short forms was not statistically significant. The BPI was more responsive to the clinical intervention than the SF-36 Bodily Pain and PROMIS Pain Interference measures. Post hoc analyses exploring these findings did not suggest that differences in content or rating scale structure (number of response options or anchoring language) adequately explained the observed differences in the detection of change.

conclusionsIn this clinical trial, the BPI and PEG measures were better able to detect change than the SF-36 Bodily Pain and PROMIS Pain Interference measures.

Indexed as

Comparative Effectiveness ResearchAdultAgedFemaleHumansMaleMiddle AgedMusculoskeletal PainPain MeasurementROC CurveSensitivity and SpecificityTelemedicine

Identifiers

PMID26807536
PMCPMC4792763
OpenAlexW2266967734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.